PHARMA INSIGHT
0865.904.944 · rovalta.com · 23/09/2026
NORMAL SITUATION
PHARMA INSIGHT
Financial year 2023 · closed on 31/12/2023
Net result
1,2 M €
+3.5% YoY
Revenue
17 M €
+12.0% YoY
Equity
5,8 M €
+25.0% YoY
Workforce
141,7 ETP
-13.0% YoY
Company — Normal situation.
Overview
What does PHARMA INSIGHT do?
PHARMA INSIGHT is a company registered in Belgium. It employs on average 141,7 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0865.904.944
Legal form
Private limited company
Contributed capital
18 600,00 €
Latest accounts
31/12/2023
Average workforce
141,7 ETP
Joint committees (2)
- 200
- 218
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 12 financial years
| 2023 | 2022 | 2021 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||
| Revenue | 17 M € | +12.0% | 15,2 M € | +9.5% | 13,9 M € | – | – | – | – | – | – | – | – | – | |||||||||
| EBITDA | 1,9 M € | +1.8% | 1,8 M € | +30.7% | 1,4 M € | -10.5% | 1,6 M € | +132% | 674,5 k € | +188% | 234,4 k € | -6.8% | 251,5 k € | -39.4% | 414,8 k € | +10.7% | 374,8 k € | +18.5% | 316,3 k € | +66.3% | 190,2 k € | +24.9% | 152,3 k € |
| Operating result | 1,8 M € | +1.5% | 1,8 M € | +32.5% | 1,4 M € | -9.6% | 1,5 M € | +137% | 633,5 k € | +224% | 195,4 k € | -7.1% | 210,2 k € | -47.0% | 396,5 k € | +10.2% | 359,8 k € | +22.0% | 295 k € | +71.3% | 172,2 k € | +25.3% | 137,4 k € |
| Net result | 1,2 M € | +3.5% | 1,1 M € | +47.1% | 755,6 k € | -16.4% | 904,1 k € | +146% | 368 k € | +358% | 80,4 k € | -33.8% | 121,4 k € | -48.8% | 236,9 k € | +9.4% | 216,4 k € | +17.3% | 184,5 k € | +78.6% | 103,3 k € | +13.5% | 91,1 k € |
| Balance sheet | |||||||||||||||||||||||
| Equity | 5,8 M € | +25.0% | 4,6 M € | +31.8% | 3,5 M € | +78.1% | 2 M € | +85.3% | 1,1 M € | +53.2% | 692,2 k € | +13.1% | 611,8 k € | -31.3% | 890,4 k € | +36.2% | 653,6 k € | +49.5% | 437,1 k € | +73.0% | 252,7 k € | +69.2% | 149,3 k € |
| Total assets | 8,1 M € | -0.6% | 8,1 M € | +33.8% | 6,1 M € | +36.4% | 4,4 M € | +61.1% | 2,8 M € | +81.0% | 1,5 M € | +9.6% | 1,4 M € | -7.7% | 1,5 M € | +41.8% | 1,1 M € | +30.1% | 817,7 k € | +71.8% | 476 k € | +72.8% | 275,4 k € |
| Cash | 59,2 k € | +12.4% | 52,7 k € | -44.8% | 95,5 k € | -89.1% | 878,9 k € | +35.6% | 648,1 k € | +132% | 279,1 k € | +12.9% | 247,3 k € | -61.2% | 638,1 k € | +9.3% | 584 k € | +56.5% | 373,1 k € | +151% | 148,4 k € | +26.6% | 117,3 k € |
| Debts | 2,3 M € | -34.3% | 3,5 M € | +36.6% | 2,6 M € | +4.2% | 2,5 M € | +53.5% | 1,6 M € | +94.8% | 822,4 k € | +5.9% | 776,5 k € | +25.8% | 617,3 k € | +53.0% | 403,6 k € | +6.0% | 380,6 k € | +71.1% | 222,4 k € | +76.4% | 126,1 k € |
| Other | |||||||||||||||||||||||
| Workforce | 141,7 ETP | -13.0% | 162,8 ETP | +1.1% | 161,1 ETP | +190% | 55,5 ETP | +48.4% | 37,4 ETP | +42.7% | 26,2 ETP | +12.0% | 23,4 ETP | +36.0% | 17,2 ETP | +37.6% | 12,5 ETP | +50.6% | 8,3 ETP | +118% | 3,8 ETP | +171% | 1,4 ETP |
Governance
Board of directors
Seen on filing of 31/12/2023 · 3 active · 11 ended
Active mandates
Ended mandates
Financials
Annual accounts
Full financial information
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 08/07/2024 | 04/07/2023 | 01/07/2022 | 23/06/2021 | 26/06/2020 | 28/06/2019 |
| General meeting | 28/06/2024 | 30/06/2023 | 31/05/2022 | 31/05/2021 | 29/05/2020 | 31/05/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2023 | 28/06/2024 | 08/07/2024 | Dutch | |
| Full model | 31/12/2022 | 30/06/2023 | 04/07/2023 | Dutch | |
| Full model | 31/12/2021 | 31/05/2022 | 01/07/2022 | Dutch | |
| Full model | 31/12/2020 | 31/05/2021 | 23/06/2021 | Dutch | |
| Full model | 31/12/2019 | 29/05/2020 | 26/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 31/05/2019 | 28/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 31/08/2018 | 31/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 02/10/2017 | 16/10/2017 | Dutch | |
| Full model | 31/12/2015 | 05/10/2016 | 06/10/2016 | Dutch | |
| Abridged modelCorrection | 31/12/2014 | 24/06/2016 | 18/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/08/2015 | 10/09/2015 | Dutch | |
| Abridged modelCorrection | 31/12/2013 | 24/06/2016 | 18/07/2016 | Dutch | |
| Abridged model | 31/12/2013 | 26/09/2014 | 30/09/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/07/2013 | 22/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 27/09/2012 | 28/09/2012 | Dutch | |
| Abridged model | 31/12/2010 | 26/08/2011 | 29/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 23/06/2010 | 12/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 27/08/2009 | 28/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 30/06/2008 | 06/08/2008 | Dutch | |
| Abridged model | 31/12/2006 | 31/05/2007 | 20/06/2007 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2023 · 3 active · 11 ended
Active mandates
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Restructuring17/07/2024KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 20231,2 M €↑
- 2022Annual accounts 20221,1 M €↑
- 2021Annual accounts 2021755,6 k €↓
- 2014Annual accounts 2014904,1 k €↑
- 2013Annual accounts 2013368 k €↑
- 2012Annual accounts 201280,4 k €↓
- 2011Annual accounts 2011121,4 k €↓
- 2010Annual accounts 2010236,9 k €↑
- 2009Annual accounts 2009216,4 k €↑
- 2008Annual accounts 2008184,5 k €↑
- 2007Annual accounts 2007103,3 k €↑
- 2006Annual accounts 200691,1 k €